To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Clinical Research CoordinatorThe Clinical Research Coordinator (CRC) is responsible for conducting clinical trials using Good Clinical Practices [1] (GCP) under the auspices of the Principal Investigator (PI). Good Clinical Practices Principles have been defined by Madelene Ottosen, RN, MSN, of The University of Texas Health Science Center at Houston [1] as:
Although the PI is responsible for the conduct of the trial, “it has been said that the CRC is the heart and soul of the research study and that, ultimately, it is the CRC who carries forward the research goals, thereby playing a significant role in the success of the research study. Most importantly, CRCs are often involved in essential duties that have been traditionally performed by the PI, such as conducting the informed consent process and ensuring compliance with the protocol” [2]. The CRC’s primary responsibility, as with all clinical research professionals, is the protection of human subjects, but the CRC has many other responsibilities. Although not inclusive, some of the CRC responsibilities include preparing the Institutional Review Board submission, writing the informed consent document, working with the institutional official in contract negotiations , developing a detailed cost analysis, negotiating the budget with the Sponsor (i.e. pharmaceutical company or granting agency), subject recruitment, patient care, adverse event reporting, preparing the case report form (CRF), submitting CRFs and other data to the Sponsor as necessary and study close-out. Additional recommended knowledge
Clinical Research Coordinator ResponsiblitiesInstitutional Review Board SubmissionsMain Article: Institutional Review Board All research involving human subjects must be approved by an Institutional Review Board. Each IRB has requirements for protocol submissions which usually require the preparation of an IRB application and informed consent document. A study cannot begin unless IRB approval is obtained. Informed ConsentThe IRB must approve the informed consent prior to study initiation and often the CRC is liaison between the IRB and the sponsor. The sponsor will have set requirements of the informed consent as does the IRB. Each local IRB is responsible for the review and approval of the informed consent, but the CRC is responsible for the communication between the IRB and the sponsor. §46.116 of the Code of Federal Regulations[3] outlines the elements of informed consent as:
(A) Basic elements of informed consent
(B) Additional elements of informed consent.When appropriate, one or more of the following elements of information shall also be provided to each subject:
Contracting with Pharmaceutical CompaniesThe site conducting the clinical trial will negotiate the clinical trial agreement (CTA) to conform to its policies and procedures. The resolution of many contractual issues requires coordination between the sponsor, the PI and the site, which is usually responsibility of the CRC. The involvement of each party is essential to a successful CTA with mutually acceptable terms. The CTA should include terms for indemnification, confidentiality, publication, intellectual property, insurance, data safety and monitoring boards, subject injury, governing law and termination clauses. Cost Analysis and Budget NegotiationsTo develop a cost analysis, the CRC will review the protocol schema and determine which procedures are standard of care versus research. The research charges will be included in the budget along with personnel effort, site initiation costs, IRB fees throughout the life of the clinical trial, pharmacy costs, travel costs for the PI and CRC to attend Investigator meetings, equipment, dedicated fax and computer lines, supplies, screen failures, subject stipends, subject travel costs, and any other items that are defined as a direct cost to the clinical trial. In addition, if the clinical trial is conducted at an Academic Medical Center (AMC) there will be an indirect cost rate that will be applied to the direct costs of the study. The indirect rate is approximately 30% for pharmaceutical trials and can be upwards of 50% for federal trials, depending on the AMC’s federally negotiated indirect costs rate[4]. Subject RecruitmentPrior to agreeing to conduct the clinical trial, the CRC (and the PI) will determine if they have the appropriate patient population. The CRC is responsible for subject recruitment once the trial begins or establishing the research team that will recruit subjects. It is important that viable subject recruitment occurs beforehand as the clinical trial agreement will stipulate the number of subjects the site is required to recruit. Patient CareThe CRC will coordinate and conduct patient care visits and assure all procedures are conducted in compliance with the protocol. The CRC will interact with the PI to assure patient receives appropriate medical evaluation and care when needed and will alert the PI of any serious adverse events that may occur throughout the course of the study. Adverse EventsMain Article: Adverse event An adverse event is described as “any adverse change in health or "side-effect" that occurs in a person who participates in a clinical trial while the patient is receiving the treatment (study medication, application of the study device, etc.) or within a pre-specified period of time after their treatment has been completed.” The CRC must report all adverse events to the IRB and the sponsor. Preparing and Submitting Case Report FormsMain Article: Case Report Form The purpose of the Case Report Form (CRF) is to collect relevant data in accordance with the protocol and in compliance with regulatory requirements. The CRC will collect the data on the CRF and submit to the sponsor either electronically or paper format. Study Close-OutIn accordance with the local IRB, the CRC will complete IRB study close-out documentation and make any appropriate notifications to the study subjects, research team, and pharmacies. The CRC will work with the sponsor’s clinical monitor in completing outstanding monitoring findings and queries. In addition, the CRC is responsible form complying with the record retention policies of the Food and Drug Administration (FDA), the ICH, and the clinical trial agreement. Clinical Research Coordinator CertificationThere are two organizations that provide certification for the CRCs: Association of Clinical Research Professionals[5] (ACRP) and the Society of Clinical Research Associates[6] (SoCRA). ACRP offers the designation of Certified Clinical Research Coordinator and SoCRA offers the designation of Certified Clinical Research Professional. SoCRA established the Certification Program for Clinical Research Professionals in order to “create an internationally accepted standard of knowledge, education, and experience by which clinical research professionals will be recognized by the medical research community.” See also
ReferencesCategories: Clinical research | Pharmaceutical industry |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Clinical_Research_Coordinator". A list of authors is available in Wikipedia. |